http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110093373-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-907
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110093373-B
titleOfInvention Construction method of AFFT2 cells
abstract The invention belongs to the technical field of biology, and particularly relates to a construction method of AFFT2 cells. The method modifies cells by using a TCR-T technology, the modified T cells are sealed in vitro by using inhibitory signal molecule antibody medicines, so that the anti-tumor capacity of the T cells is effectively improved, and the proportion of specific T cells for recognizing tumor antigens of the cells modified by the AFFT2 scheme is more than 70%.
priorityDate 2018-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16768
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171285
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID74048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84868
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100536120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1493
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID297596
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281732
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID201633
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID151888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID208154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3902

Total number of triples: 48.